Background
==========

Men who have sex with men (MSM) remain a vulnerable population for HIV infection across the world \[[@B1]\]. In Brazil, HIV prevalence among the general population is below 0.6% \[[@B2]\]. However, in the largest study conducted in the country, HIV prevalence among MSM ranged from 9.1% to 16% \[[@B3]\]. Soon after the onset of the HIV epidemic, there were reductions in transmission among MSM due to the expansion of condom use \[[@B4]\] or even sexual abstinence \[[@B5],[@B6]\]. Although condoms represent an effective barrier against sexual transmission, since the mid-1990s the proportion of men reporting unsafe sex -- including "barebacking", i.e. unprotected anal intercourse (UAI) in a risk context \[[@B7]\] -- seems to have increased \[[@B8]-[@B11]\].

UAI is the main HIV transmission route among MSM \[[@B12]\]. Studies designed to increase the understanding about this sexual practice in the different cultures and how it relates to HIV transmission, re-infection and development of HIV antiretroviral resistance may have important public health implications. A meta-analysis from studies conducted in the US estimated an overall UAI prevalence among HIV-infected MSM at 43% (CI 95% 37--48) \[[@B12]\], with lower frequencies when sexual partners were of unknown (30%) or negative (16%) serostatus \[[@B12]\]. These differences may be related to the "sexual harm-reduction" approaches, such as serosorting (the use of the partners' HIV serostatus - actual or presumed - as a guidance to make decisions when having UAI), strategic positioning (selectively engage in receptive UAI rather than insertive UAI) and negotiated safety (as agreements between steady couples related to sex with casual partners) \[[@B13]-[@B16]\].

Data on UAI prevalence and associated factors among Brazilian MSM are scarce, which limits the effectiveness of public policies designed to decrease HIV infection in this population. In a study conducted with over 3,000 HIV-positive and negative Brazilian MSM, UAI prevalence was 36.5%, and the associated factors reported were in accordance with the international literature \[[@B17]\]. However, the authors did not disaggregate data according to HIV serostatus, precluding inferences about attitudes and behaviors associated to HIV transmission.

Behavioral and contextual factors, specifically a higher number of sexual partners \[[@B18]-[@B20]\], a history of domestic or sexual violence \[[@B21],[@B22]\], alcohol and illicit drug use, particularly stimulants \[[@B23]-[@B27]\], have been associated with UAI among MSM in the international literature. Given the importance of combined anti-retroviral therapy (cART) in the treatment and prevention of HIV infection \[[@B28]\], researchers have also investigated the potential impact of its use, and consequential undetectable viral loads, on UAI reporting. Even though some results showed an increase in UAI among individuals with known undetectable viral load (UVL) \[[@B29]\] or with the belief that UVL decreases transmission \[[@B30]\], most evidence suggest that there is no association between UAI and UVL/cART use \[[@B31]-[@B34]\].

Considering the sustained high incidence rate of HIV among MSM and the lack of information on UAI among HIV-infected South American MSM, this paper aims to study the prevalence and associated factors of UAI among HIV-infected MSM in Brazil.

Methods
=======

A cross-sectional analysis, nested within a cohort study was conducted at Instituto de Pesquisa Clinica Evandro Chagas (IPEC/FIOCRUZ), Rio de Janeiro, Brazil. A convenience sample of HIV--infected and non-infected high risk MSM older than 18 years was enrolled since 2010. Briefly, the cohort was designed to evaluate the prevalence and incidence of anal HPV infection and intraepithelial anal lesions. Participants were considered to be MSM if they had a male sexual partner (s) in the past 12 months, regardless of having a female partner (s).

Participants
------------

The study population for the present analysis was a subset of HIV-infected MSM enrolled in the parent cohort, who reported having had anal intercourse with men at risk for HIV infection (HIV negative or with an unknown HIV serostatus) within the past 3 months.

Two hundred ninety four HIV-infected MSM were enrolled into the IPEC/FIOCRUZ men's cohort from August 2, 2010 to June 30, 2012. Of these 294 MSM, a total 190 MSM were excluded from this analysis for the following reasons: 85/294 (28.9%) reported no male sexual partner/no anal intercourse in the past 3 months; 34/294 (11.6%) reported anal intercourse exclusively with an HIV-infected male partner; and 20/294 (6.8%) had missing data for anal intercourse data (Figure [1](#F1){ref-type="fig"}). Final sample was comprised by 155 HIV-infected MSM.

![Study population and outcome, IPEC/Fiocruz, 2010--2012.](1471-2458-14-379-1){#F1}

Measures
--------

The outcome was defined as UAI with at least one man of unknown or negative HIV status in the 3 months preceding the interview.

*Demographic variables* were collected at enrollment visit and included: age, self-reported skin color (white and non-white) and schooling (years of formal education).

*Data on behavior variables were* collected during the enrollment visit via Audio Computer Assisted Interview (ACASI), which included the following:

*Number of male partners* within the last 12 months ("During the past 12 months, how many men and how many transvestite/transsexual/transgender (s) did you have sex with?");

*Anal intercourse practices in the past 3 months* was measured through the following questions: a-"In the past 3 months, how many HIV-negative male partners did you have insertive anal sex with?"; b-"In the past 3 months, how many male partners, with an unknown HIV-serostatus, did you have insertive anal sex with?"; c- "In the past 3 months, how many HIV-negative male partners did you have receptive anal sex with?"; d-"In the past 3 months, how many male partners, with an unknown HIV-serostatus, did you have receptive anal sex with?". The questions above were used to select the study population and were also used to formulate the variable "Anal intercourse practices" and its subcategories of \*only insertive\*, \*only receptive\* or \*both\*.

*Unprotected anal intercourse in the past 3 months* was measured by the following questions: a- "In the past 3 months, how many HIV-negative male partners did you have insertive anal sex with, without using condoms?"; b- "In the past 3 months, how many HIV-unknown male partners did you have insertive anal sex with, without using condoms?"; c- "In the past 3 months, how many HIV-negative male partners did you have receptive anal sex with, without using condoms?"; d- "In the past 3 months, how many male partners, with an unknown HIV-serostatus, did you have receptive anal sex with, without using condoms?".

*Alcohol use, either before or during sex,* within the past 3 months was measured by the question "In the past 3 months, were you drunk or high before or during sex?");

*Stimulant use, either before or during sex,* within the past 3 months was measured by the question "In the past 3 months, did you use either inhaled or intravenous illicit drugs before or during sex?"; *Lifetime injection drug use* was measured by the question "Have you ever used intravenous illicit drugs in your life?"; however, due to limited observations, this response was not evaluated in the models.

*Commercial sex within the past 3 months* was defined as the exchange of sex for money/other favors and/or the looking for prostitutes: "In the past 3 months, did you have sex for money, drugs or other favors?" and "In the past 3 months, did you look for prostitutes?".

*A lifetime history of sexual abuse or violence was determined based on a* composite measure of the responses to the following 2 questions: "Did you ever suffer domestic violence in your life?" and "Did you ever suffer sexual abuse in your life?");

*The Clinical and laboratory variables* included the following:

*Time since HIV diagnosis* was defined as the time since the first HIV-positive serology result until the date of the interview; results were presented using the median (interquartile range).

*Combined antiretroviral therapy (cART)* was defined as the date of issuance of the initial prescription for combined antiretroviral treatment until the date of the interview. Individuals who have a cART prescription were classified as receiving cART.

*CD4*^*+*^*T cell count (cells/mm*^*3*^*) was defined as* the available result closest to the date of the interview. The specimens to measure CD4^+^ T cell count were obtained within a window period of 6 months before and up to 3 months the interview. Data was presented as median and interquartile range.

*HIV viral load (copies/IU).* Specimens were collected on the day of the interview and results were classified as either undetectable (less than 400 copies/IU) or detectable (equal to/higher than 400 copies/IU).

All biological analyses were performed at the IPEC Laboratories, which successfully participates in the College of American Pathologists (CAP) External Quality Assurance (EQA) proficiency testing panels and is certified by the Division of AIDS' Virology Quality Assurance (VQA) program for quantitative and qualitative HIV assays.

Statistical analysis
--------------------

Descriptive analysis and proportions of men who reported UAI in the past 3 months were presented. Chi-square tests and Fisher exact tests were used for categorical variables, and Student *t* test were used for continuous variables. Generalized linear models with logit link and binomial distribution \[[@B35]\] were used to identify independent variables associated with UAI in the past 3 months in the study population. Age (years) and the number of male partners in the last 12 months were modeled as restricted cubic splines with three knots \[[@B36]\].

After univariate analysis, observations with missing information on any selected variable were excluded. Covariates with p values \<0.10 were selected, assessed for multi-colinearity using generalized colinearity diagnostics (GVIF) and entered in the initial multivariate model. Based on prior information concerning the effect of age in HIV incidence \[[@B37]\], we forced *a priori* the variable age as a continuous variable into the multivariate models. Covariates with the highest p values in the analysis of deviance (analogous to the likelihood ratio test) were sequentially removed. Variables with statistical significance at 5% (p \< 0.05) and those that were not considered a confounder (e.g., when removed, a change equal to or higher than 10% in the odds ratio of any other variable of the model was observed) remained in the final model \[[@B38]\]. The Akaike Information Criterion (AIC) was also used for model selection. The Le Cessie-van Houwelingen-Copas-Hosmer test was used to evaluate the goodness-of-fit of the final model \[[@B39]\]. The predictive ability was evaluated using the Area Under the ROC Curve (AUC). Overdispersion was verified as well as the analysis of the residuals (Pearson and deviance residuals and Leverage or Cook's distances). The software R 3.0.2 was used to generate all analyses \[[@B40]\].

Ethics
------

The study was approved by the IPEC-FIOCRUZ IRB (CAE 0044.0.009.000-09) and all study participants signed an informed consent form prior to enrollment into the cohort.

Results
=======

One hundred and fifty five MSM who reported anal sex with either an HIV-negative partner or a male partner with an unknown HIV-serostatus within the past 3 months were included. Overall, UAI with an HIV-negative or unknown HIV-serostatus male partner was reported by 40.6% (63/155) of MSM: 7.9% were exclusively with an HIV-negative partner, 76.2% were exclusively with a partner with unknown HIV-serostatus and 15.9% with both, as shown in Table [1](#T1){ref-type="table"}.

###### 

Unprotected anal intercourse according to partner (s) HIV-serostatus, IPEC/FIOCRUZ, 2010--2012

  **HIV partner serostatus**    **Unprotected anal intercourse within the past 3 months**                             
  ---------------------------- ----------------------------------------------------------- ------- ---- ------- ----- -------
  Only HIV-negative                                        23                               25.0    5     7.9    28    18.1
  Only unknown HIV                                         57                               62.0    48   76.2    105   67.7
  Both                                                     12                               13.0    10   15.9    22    14.2
  Total                                                    92                               100.0   63   100.0   155   100.0

Table [2](#T2){ref-type="table"} describes the sociodemographic, behavioral, clinical and laboratorial characteristics of the study participants by UAI. Median age was 38 years, 53.6% were self-identified as white and 84.2% had more than 8 years of formal education. No significant differences at p \< 0.10 level were observed in chance of UAI and skin color (*P* = 0.799) and years of education (*P* = 0.882). The median number of male sexual partners in the 12 months prior to the interview was 6.0; it was higher among those who reported UAI (Median = 10; ***P*** **= 0.038**). Having only a single partner during the 12 months prior to the interview was reported by 12.4%.

###### 

Characteristics of UAI with an HIV negative/unknown serostatus partner within last 3 months (N = 155), IPEC/FIOCRUZ, 2010--2012

                        **Characteristics**  **Unprotected anal intercourse**      **P-value\***                           
  ----------------------------------------- ---------------------------------- --------------------- --------------------- -------
                                    Age\*\*          40.5 (31.5-48.0)            37.0 (32.0-43.0)       38 (32.0-45.0)      0.107
                                      White             48 (52.7)                    34 (54.8)             82 (53.6)        0.799
                         Years of education                                                                                 0.882
                                       \< 4              5 (5.6)                      2 (3.2)               7 (4.6)            
                                      4 a 8             10 (11.1)                    7 (11.3)              17 (11.2)           
                                       \> 8             75 (83.3)                    53 (85.5)            128 (84.2)           
     No of male partners last 12 months\*\*           5.0 (2.0-10.0)              10.0 (3.0-30.0)       6.0 (3.0-15.0)      0.038
          Lifetime sexual abuse or violence             23 (25.0)                    32 (52.5)             55 (35,9)        0.001
       Alcohol use before sex last 3 months             31 (33.7)                    26 (41.3)             57 (36,8)        0.337
     Stimulant use before sex last 3 months             14 (15.2)                    17 (27.0)             31 (20.0)        0.072
               Commercial sex last 3 months             34 (37.0)                    41 (65.1)             75 (48.4)        0.001
    Anal intercourse with men last 3 months                                                                                 0.002
                             Only insertive             14 (15.2)                    11 (17.5)             25 (16.1)           
                             Only receptive             33 (35.9)                    7 (11.1)              40 (25.8)           
                                       Both             45 (48.9)                    45 (71.4)             90 (58,1)           
             Months since HIV diagnosis\*\*         70.7 (33.3-162.4)            75.0 (44.1-134.5)     72.0 (33.8-148.8)    0.866
                             Receiving cART             80 (87.0)                    46 (74.2)            126 (81.8)        0.044
                 CD4 count (cels/mm^3^)\*\*        541.5 (381.0-759.0)          647.0 (414.0-927.0)   581.0 (393.0-837.0)   0.116
                    Undetectable viral load             47 (51.6)                    28 (50.0)             75 (51.0)        0.846

\*Chi-square test or Fisher's exact test were applied for categorical variables. Student *t* test was used for continuous variables.

\*\*Median (IQR).

\*\*\*Proportions were calculated over the valid number of the cases: Receiving cART (n = 154); White, No of male partners last 12 months, Lifetime sexual abuse or violence, Stimulant use before sex last 3 months (n = 153); Years of education (n = 152); Months since HIV diagnosis (n = 146); CD4 count (n = 143).

Lifetime sexual abuse or domestic violence was reported by 35.9% and was significantly greater among MSM who reported UAI compared to those who did not (p = 0.001). Although 36.8% of MSM reported to be "high" from alcohol use before/during sex in the past 3 months, this was not statistically different from those who reported UAI and those who did not report UAI (*P* = 0.337). Stimulant usage before/during sex in the past 3 months was reported by 20.0% of the MSM, being slightly higher among those who reported UAI when compared to the group who did not. (27.0% vs. 15.2%; *P* = 0.072). Only 4 study participants (2.6%) reported injecting drug use during their lifetime.

Commercial sex in the past 3 months was frequent among all MSM (48.4%) and positively associated with UAI (***P*** **= 0.001**). 58.1% participants reported both insertive and receptive sexual practices, while an exclusively insertive sexual practice was reported only by 16.1%. UAI was less frequently reported in exclusively receptive MSM (11.1%) when compared to those with exclusively insertive (17.5%) or with both insertive and receptive sexual practices (71.4%). (***P*** **= 0.002**).

The median time since HIV diagnosis was 72.0 months and this was not associated with UAI (*P* = 0.866). Almost 82% of MSM were receiving cART at the time of the interview; this was associated with a lower likelihood of UAI (***P*** **= 0.044**). Median CD4 count was higher among MSM who had UAI compared to those who did not report UAI, although no significance was observed at 10% (*P* = 0.116). Roughly half of the participants had an undetectable HIV viral load; this was not associated to a higher likelihood of having UAI (*P* = 0.846).

Multi-colinearity was not observed among significant variables (P \< 0.10) and age after univariate analysis, which were entered in the initial multivariate model. In the final multivariate model (Table [3](#T3){ref-type="table"} and Figure [2](#F2){ref-type="fig"}), reporting sexual abuse or domestic violence (OR = 2.70; 95% CI: 1.08-7.01) and having commercial sex within the past 3 months (OR = 2.28; 95% CI: 1.04- 5.10) were positively associated with UAI, whereas the practice of exclusively receptive anal intercourse (OR = 0.21; 95% CI: 0.06-0.75) was negatively associated with UAI. The shape of the association between the number of male partners in the past 12 months and UAI (modeled as the restricted cubic spline with 3 knots: 1.0, 6.0, 35.0) showed that the chance of UAI for each additional male partner increased quickly among participants who reported up to 20 partners and slowly among those who reported more than 20 (p-value = 0.039). Stimulants use before or during sex and receiving cART remained as confounder variables in the final multivariate model. Despite not having a statistically significant impact on UAI, the shape of association for age (years modeled as the restricted cubic spline with 3 knots: 26.1, 38.5, 51.0) is rather flat, though there is a low chance of UAI at the age extremes (p-value = 0.301). There was no overdispersion in the model and the goodness-of-fit as well as the residual analysis were satisfactory.

###### 

Factors associated with unprotected anal intercourse among MSM who have sex with an HIV negative/unknown serostatus partner within the last 3 months (N = 152)\*, IPEC/Fiocruz, 2010-2012\*\* \*\*\*

                **Characteristics\* \*\***  **Adjusted OR (CI 95%)**   **P-value**
  ---------------------------------------- -------------------------- -------------
         Lifetime sexual abuse or violence     2.70 (1.08 - 7.01)         0.034
    Stimulant use before sex last 3 months     1.48 (0.57 - 3.83)         0.418
              Commercial sex last 3 months     2.28 (1.04 - 5.10)         0.040
            Anal intercourse last 3 months                                   
                            Only insertive             1                     
                            Only receptive     0.21 (0.06 - 0.75)         0.018
                   Receptive and insertive     0.75 (0.25 - 2.22)         0.603
                            Receiving cART     0.52 (0.18 - 1.47)         0.218

Le Cessie-van Houwelingen-Copas-Hosmer test (P-value): 0.723; AUC: 0.795.

\*Three MSM were excluded from initial multivariate model due to missing data in at least one covariate.

\*\*Age was forced *a priori* the variable age into the multivariate models; Number of male partners, Stimulant use before sex, and currently receiving cART was a confounder and remained in the final multivariate model.

\*\*\*Age (years) and Number of male partners within the last 12 months were modeled as restricted cubic spline with three knots (coefficients not shown).

![Restricted cubic spline analysis of the functional form of the association between age (years) and number of male partners in the last 12 months and the unprotected anal intercourse in the final model, IPEC/Fiocruz, 2010--2012.](1471-2458-14-379-2){#F2}

Discussion
==========

Most HIV -infected from our study have reported that they did not know their partner's serostatus, which is in accordance with prior data from Latin America \[[@B41]\]. The frequency of UAI with either negative or unknown HIV status partners was higher (40%) than that described in a meta-analysis conducted with HIV positive MSM from the U.S. (26%) \[[@B12]\]. Therefore, the risk of transmission, as well as re-infection and other sexually transmitted disease (STD) acquisition is increased among this population. Brazilian efforts on prevention, especially promoting condoms use and providing freely cART, have been very efficient in the control of HIV epidemics among general population \[[@B2]\]. However, they were not enough to control HIV transmission among MSM, a population presenting 10.5% HIV point prevalence \[[@B42]\]. Thus, the UAI prevalence data presented in this study indicate that other effective interventions, such as Post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) \[[@B43]-[@B45]\], are needed as additional prevention tools to vulnerable MSM.

The lifetime history of violence or sexual abuse increased the chances of UAI by almost 3 times. This outcome is particularly concerning seeing that the frequency of UAI for the study population was 40.6%, with greater than half of the men who had UAI reporting previous violence or sexual abuse. Increasing evidence supports the associations of both childhood sexual abuse and intimate partner violence with sexual risk behavior in MSM. An intervention trial \[[@B21]\] aimed to reduce risk behavior in MSM in six American cities found a 39.7% point prevalence of reported child sexual abuse, which was associated with a 1.24 (95% CI: 1.12 to 1.36) increased chance of UAI. Similarly, a positive association was found between intimate partner violence and UAI, depression, and substance abuse among 814 MSM from Chicago \[[@B46]\]. Less is known on these issues in middle-income countries \[[@B47]\] and there are still methodological problems to be solved regarding definitions and study design \[[@B48]\], but results found here point to an important and under evaluated threat to health among this population.

Commercial sex within the past 3 months also increased the likelihood of UAI in MSM. In our study, this variable included both MSM who received money in exchange for sex and/or looked for sexual partners on the streets. Because commercial sex is illegal in many countries, accurately assessing frequency of commercial sex is difficult. As a result, the research data on the association of commercial sex with UAI may be underreported and its association with UAI may be therefore difficult to measure. In a sample of MSM who paid for sex in Pakistan, almost 60% of them reported that their last intercourse event was unprotected \[[@B49]\]; however, more than 80% of interviewed MSM from India reported to have used condoms during their last paid intercourse with other men \[[@B50]\].

Results are also contradictory on the risk of HIV infection among MSM who exchanged sex for money. A meta-analysis from studies conducted in China found no difference in the HIV infection risk for "money-boys" compared to other MSM \[[@B51]\]. However, in a small recent study, including 463 Chinese MSM from the general population, commercial sex increased the chance of HIV infection by 4 times (95% 1.19-13.69) \[[@B52]\]. Even less is known about commercial sex among HIV-infected MSM, including possible cultural differences related to stigma and discrimination that may play a factor in the ability to negotiate the use of safe sex practices. As a result, additional research is still necessary on this topic.

Most MSM (57%) reported both insertive and receptive anal intercourse during the last 3 months, which is in accordance with the international literature \[[@B53],[@B54]\]. MSM who reported having only receptive anal intercourse reported less UAI compared to those who only had insertive sex. These findings may be related to an increased awareness with one's own health and an intention to protect themselves from super-infection and STD. These data also raise questions about serosorting and strategic positioning as risk reduction practices among Brazilian MSM. Further studies are necessary to evaluate these practices and risk reduction strategies adopted by HIV-positive MSM and their impact on HIV transmission.

The chance of UAI was associated with the number of male sexual partners within the past 12 months (P = 0.039). However, we could observe that for MSM who had more than 20 male sexual partners, the odds of UAI for each additional partner did not increase as quickly when compared to participants who reported up to 20 partners.

In accordance with the recent literature, viral load and cART use \[[@B55],[@B12]\] were not associated with UAI in this study. In contrast to the available literature, our findings indicated that being a younger age and being "high" from alcohol use or recreational stimulant use before/during sex were not associated with UAI. However, these findings must be interpreted with caution and the lack of statistical significance may be associated with the small size of our study population. Alcohol and stimulant consumption may be used to increase sexual performance \[[@B56]\], but intoxication decreases risk perception of HIV transmission \[[@B57]\]. Studies conducted with HIV-infected MSM have found a positive association between sexual risk behavior and the excessive consumption of alcoholic beverages \[[@B58],[@B30]\].

Lastly, it is important to highlight that subjects who reported UAI also reported a higher number of sexual partners, a higher frequency of lifetime history of violence, and had a higher frequency of alcohol and stimulant use before/during sex than MSM who had no UAI. Different theories have been proposed to explain the clustering of different health problems/risky behaviors within the same populations. Dr. Merrill Singer, for example, has proposed the concept of syndemics \[[@B59]\], meaning different problems act synergistically in the worsening of health. Several authors have studied the concept of internalized homophobia as a predictor of risky behavior and psychological issues among MSM \[[@B60]-[@B62]\]. These theories are far from disentangling the multiple components related to risky behavior, and there is a debate on their real impact on health \[[@B63]\], but they certainly reinforce the need for a comprehensive approach on treating and preventing HIV among MSM.

As our sample is not probabilistic - and results may not be generalized to a broader population - further research is needed. Nevertheless, our results offer insight on factors associated with unprotected sexual practices among HIV-infected MSM in Brazil. As a limitation, the study was not specifically designed to evaluate intimate partner violence, sexual abuse or other kinds of violence, and as a result the measures were not standardized accordingly. However, given the large prevalence of these factors, those findings indicate a pressing need for studies to support targeted interventions for Brazilian MSM.

Conclusions
===========

Most MSM included in the present study were not aware of their partner's HIV serostatus. The high prevalence of UAI with HIV negative or with unknown HIV status male partners indicates that additional prevention strategies are urgently needed for this population. The factors associated with UAI in our study included a lifetime history of violence or sexual abuse, commercial sex and the number of male sexual partners in the past 12 months. The clustering of different health, behavioral, and social problems among these MSM reinforces the need for a comprehensive approach towards treatment and prevention of HIV in this population.
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